Ney Carter Borges/LinkedIn
Apr 2, 2026, 16:08
Ney Carter Borges: Early Surgery vs Conservative Care in Asymptomatic Very Severe Aortic Stenosis
Ney Carter Borges, Member Cardiologist of Global Physician Association at Cleveland Clinic Florida, shared a post on LinkedIn:
”Early surgery vs conservative care in asymptomatic very severe aortic stenosis (10-year outcomes)
Key findings (Recovery Trial – 10-Year Follow-up)
Population:
Asymptomatic patients with very severe aortic stenosis
(AVA ≤0.75 cm², Vmax ≥4.5 m/s)
Primary Outcome (CV death or operative mortality):
- Early Surgery: 3%
- Conservative Care: 24%
- HR 0.10 (95% CI 0.02–0.43; p=0.002)
All-Cause Mortality:
- Early Surgery: 15%
- Conservative Care: 32%
- HR 0.42 (95% CI 0.21–0.86)
Heart Failure Hospitalization:
- Early Surgery: 0%
- Conservative Care: 19%
Number Needed to Treat (10 years):
- NNT ≈ 6 (CV death)
- NNT ≈ 7 (all-cause death)
Clinical interpretation
- Early intervention dramatically reduces cardiovascular mortality
- Benefit is sustained over 10 years (no curve convergence)
- Conservative strategy leads to:
- Delayed surgery
- Higher HF burden
- Increased pre-operative risk
- Key insight: ‘Waiting for symptoms may allow irreversible myocardial damage’
Practice-changing message
In carefully selected asymptomatic patients with very severe AS, early surgical AVR should be strongly considered, especially when:
- Low surgical risk
- High transvalvular velocity
- Evidence of disease progression.”

Other posts featuring Net Carter Borges on Hemostasis Today.
-
May 24, 2026, 07:45Thierry Burnouf: Advances in Platelet Membrane-Coated Nanoparticles for Targeted Therapeutics and Regenerative Medicine
-
May 24, 2026, 07:39Shamala Thilarajah: Our Team Receives the NMRC Transition Award for NEUROACT-Stroke
-
May 24, 2026, 05:48Yazan Abou-Ismail: Contributing to the Future of von Willebrand Disease Management
-
May 24, 2026, 05:47Ali AlBahar: The Immunologic Complexity Behind ABO Blood Grouping
-
May 24, 2026, 05:46Ghaith Mansour: Honoring Scientific Collaboration at the 7th Pharmacy Research and Innovation Day
-
May 24, 2026, 04:57Ahmed Elsobky: Strengthening Hemophilia Care Under Egypt’s Universal Health Insurance System
-
May 24, 2026, 04:49Hussien Hishmat: There Is More to Pulmonary Embolism than Just Anticoagulation
-
May 24, 2026, 04:25Sarah Elkourashy: Diagnostic Challenges and Management Strategies for Maternal–Fetal Outcomes in TTP
-
May 24, 2026, 04:11Ayah Ghazi Al-Qasrawi: How Should Sepsis-Induced DIC Be Managed in Patients Receiving Thienopyridines